Estimating the period prevalence of SARS-CoV-2 infection during the Omicron (BA.1) surge in New York City (NYC), January 1-March 16, 2022
Saba A Qasmieh, View ORCID ProfileMcKaylee M Robertson, Chloe A Teasdale, Sarah G Kulkarni, View ORCID ProfileDenis Nash
doi: https://doi.org/10.1101/2022.04.23.22274214
Saba A Qasmieh
1Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY); 55 W 125th St, 6th Floor, New York, NY 10027, USA
2Department of Epidemiology and Biostatistics, Graduate School of Public Health and Health Policy, City University of New York (CUNY); 55 W 125th St, New York, NY 10027, USA
McKaylee M Robertson
1Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY); 55 W 125th St, 6th Floor, New York, NY 10027, USA
2Department of Epidemiology and Biostatistics, Graduate School of Public Health and Health Policy, City University of New York (CUNY); 55 W 125th St, New York, NY 10027, USA
Chloe A Teasdale
1Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY); 55 W 125th St, 6th Floor, New York, NY 10027, USA
2Department of Epidemiology and Biostatistics, Graduate School of Public Health and Health Policy, City University of New York (CUNY); 55 W 125th St, New York, NY 10027, USA
Sarah G Kulkarni
1Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY); 55 W 125th St, 6th Floor, New York, NY 10027, USA
Denis Nash
1Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY); 55 W 125th St, 6th Floor, New York, NY 10027, USA
2Department of Epidemiology and Biostatistics, Graduate School of Public Health and Health Policy, City University of New York (CUNY); 55 W 125th St, New York, NY 10027, USA
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
Posted April 27, 2022.
Estimating the period prevalence of SARS-CoV-2 infection during the Omicron (BA.1) surge in New York City (NYC), January 1-March 16, 2022
Saba A Qasmieh, McKaylee M Robertson, Chloe A Teasdale, Sarah G Kulkarni, Denis Nash
medRxiv 2022.04.23.22274214; doi: https://doi.org/10.1101/2022.04.23.22274214
Estimating the period prevalence of SARS-CoV-2 infection during the Omicron (BA.1) surge in New York City (NYC), January 1-March 16, 2022
Saba A Qasmieh, McKaylee M Robertson, Chloe A Teasdale, Sarah G Kulkarni, Denis Nash
medRxiv 2022.04.23.22274214; doi: https://doi.org/10.1101/2022.04.23.22274214
Subject Area
Subject Areas
- Addiction Medicine (337)
- Allergy and Immunology (664)
- Anesthesia (179)
- Cardiovascular Medicine (2607)
- Dermatology (220)
- Emergency Medicine (392)
- Epidemiology (12150)
- Forensic Medicine (10)
- Gastroenterology (752)
- Genetic and Genomic Medicine (4038)
- Geriatric Medicine (381)
- Health Economics (672)
- Health Informatics (2609)
- Health Policy (995)
- Hematology (359)
- HIV/AIDS (834)
- Medical Education (397)
- Medical Ethics (109)
- Nephrology (429)
- Neurology (3810)
- Nursing (208)
- Nutrition (567)
- Oncology (1996)
- Ophthalmology (580)
- Orthopedics (235)
- Otolaryngology (303)
- Pain Medicine (250)
- Palliative Medicine (73)
- Pathology (470)
- Pediatrics (1102)
- Primary Care Research (443)
- Public and Global Health (6478)
- Radiology and Imaging (1380)
- Respiratory Medicine (867)
- Rheumatology (396)
- Sports Medicine (337)
- Surgery (439)
- Toxicology (52)
- Transplantation (185)
- Urology (165)